The Antitrust Investigator Will See You Now: What Healthcare and Pharma Should Expect in a World of Enhanced Antitrust Scrutiny
Highlights
Healthcare entities should expect heightened government scrutiny of mergers, acquisitions, and business behaviors that could be construed as restricting competition in healthcare and pharma
The FTC, DOJ, and HHS have advanced a “whole-of-government approach,” including data sharing, cooperative enforcement, and enhanced antitrust training
Businesses should take note of practices that are likely to trigger investigatory and enforcement actions
According to media reports, the Department of Justice (DOJ) has opened an antitrust investigation into UnitedHealth Group, which is the owner of the United States’ largest health insurer, UnitedHealthcare. The focus of the inquiry appears to be the relationship between the UnitedHealthcare insurance plan and one of its health services divisions, Optum, and the potential impact on rivals and consumers.
Keep Up to Date in a Changing World
